Skip to content
healthcare.dev

BORTEZOMIB

NDC 0409-1704, BORTEZOMIB, injection, powder, lyophilized, for solution, from Hospira, Inc..

Product NDC
0409-1704
Status
Listed
Labeler
Hospira, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA209191
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0409-1704 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BORTEZOMIB1 mg/1

Pharmacologic classes

Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]

Package NDCNDC-11Package
0409-1704-01004091704011 VIAL, SINGLE-DOSE in 1 CARTON (0409-1704-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9fdf6169-699f-40eb-bda1-760253062b3c
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0409-1704

Use it

Look up 0409-1704 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0409-1704 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0409-1704. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.